Harriet Johansson
- Cancer Research top 2%
- Breast Cancer Treatment Studies 13
- Cancer, Lipids, and Metabolism 9
- Oncology top 2%
- Cancer Risks and Factors 28
- Genetics top 2%
- Estrogen and related hormone effects 37
-
- Vitamin D Research Studies 7
-
- Growth Hormone and Insulin-like Growth Factors 15
-
- Metabolism, Diabetes, and Cancer 13
- Retinoids in leukemia and cellular processes 12
- Co-authors
- Andrea DeCensiSara GandiniBernardo BonanniAliana Guerrieri‐GonzagaSara RaimondiDavide SerranoMaria Teresa SandriPatrick Maisonneuve
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- ItalyUnited StatesNorway
In The Last Decade
Harriet Johansson
80 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 710
- Oncology 1.0k
- Genetics 845
- Pathology and Forensic Medicine 452
- Endocrinology, Diabetes and Metabolism 412
Countries citing papers authored by Harriet Johansson
This map shows the geographic impact of Harriet Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet Johansson more than expected).
Fields of papers citing papers by Harriet Johansson
This network shows the impact of papers produced by Harriet Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet Johansson. The network helps show where Harriet Johansson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harriet Johansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2020 | 3 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 9 | |
| 7 | 2016 | 11 | |
| 8 | 2015 | 34 | |
| 9 | 2013 | 29 | |
| 10 | 2012 | 195 | |
| 11 | 2011 | 48 | |
| 12 | 2010 | 59 | |
| 13 | 2010 | 52 | |
| 14 | Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. | 2009 | 14 |
| 15 | 2007 | 32 | |
| 16 | 2007 | 56 | |
| 17 | 2007 | 54 | |
| 18 | Effects of low dose tamoxifen on circulating levels of hormones, C-telopeptide and HER2 extracellular domain in women with primary breast cancer | 2006 | 2 |
| 19 | Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma. | 2004 | 27 |
| 20 | 1999 | 26 |
About Harriet Johansson
Harriet Johansson is a scholar working on Genetics, Oncology and Cancer Research, having authored 83 papers that have together received 2.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (37 papers), Cancer Risks and Factors (28 papers), Growth Hormone and Insulin-like Growth Factors (15 papers), Metabolism, Diabetes, and Cancer (13 papers), Breast Cancer Treatment Studies (13 papers), Retinoids in leukemia and cellular processes (12 papers), Cancer, Lipids, and Metabolism (9 papers) and Vitamin D Research Studies (7 papers). The work is most often cited by research in Cancer Research (710 citations), Oncology (1.0k citations) and Genetics (845 citations). Harriet Johansson has collaborated with scholars based in Italy, United States and Norway. Frequent co-authors include Andrea DeCensi, Sara Gandini, Bernardo Bonanni, Aliana Guerrieri‐Gonzaga, Sara Raimondi, Davide Serrano, Maria Teresa Sandri, Patrick Maisonneuve, Massimiliano Cazzaniga and Serena Mora. Their work appears in journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.